Core Viewpoint - Charming Medical Limited has successfully completed its initial public offering (IPO) on the Nasdaq Capital Market, raising a total of $6.4 million from the sale of 1,600,000 Class A ordinary shares at a price of $4.00 per share [1][2]. Group 1: Offering Details - The IPO consisted of 1,600,000 Class A ordinary shares priced at $4.00 each, with trading commencing on October 21, 2025 [1]. - The total gross proceeds from the offering amount to $6.4 million, which will be utilized for business expansion, strategic investments, research and development, and general corporate purposes [2]. - An over-allotment option has been granted to underwriters for an additional 240,000 shares, which could increase gross proceeds to approximately $7.36 million if fully exercised [3]. Group 2: Company Background - Charming Medical Limited is a Hong Kong-based provider of Traditional Chinese Medicine (TCM)-inspired therapies and products, integrating TCM principles with modern technology [7]. - The company operates four wellness centers in Hong Kong, offering services aimed at addressing women's health issues, including womb-warming therapy and prenatal massage [7]. - Under the "Beauty Lab" brand, the company develops TCM-inspired supplements and beauty products, focusing on improving women's health and vitality [7].
Charming Medical Limited Announces Closing of Initial Public Offering